RxDoctor Payments Data

David Nemer, MD

Clinical Cardiac Electrophysiology · Columbus, OHNPI 1558709857

Payments from drug & device makers

What this record shows

This record is dominated by grants: $83,647 of the $97,340 with a category attached, or 85.9%. Abbott accounts for 64.0% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2021 at $77,842 and has fallen 98.6% since, to $1,125 in 2025. Among clinical cardiac electrophysiology clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$97,340in general payments, 2019–2025

Across 136 payments — averaging $715.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$62K
  • Medtronic$31K
  • Boston Scientific$3K
  • Biosense Webster, Inc.$734
  • Kestra Medical Technology Services, Inc.$183
  • E.r. Squibb & Sons, L.L.C.$36
  • plus $61 from 3 others

What the payments were for

  • Grants$83,64786%
  • Travel & lodging$6,7507%
  • Food & beverage$6,5977%
  • Education$3460%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$97,340 in reported general payments places this provider in the 90th percentile of 159 clinical cardiac electrophysiology providers in Ohio.

See all clinical cardiac electrophysiology providers in Ohio

Medicare billing

Part B allowed, 2024
$254,195
Medicare patients
2,373
Services billed
4,503

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban375$400,615
XareltoRivaroxaban136$143,801
EntrestoSacubitril/Valsartan13$10,353
Dofetilide41$8,696
Dabigatran EtexilateDabigatran Etexilate Mesylate36$7,357
Flecainide Acetate168$5,588
Metoprolol Succinate268$3,761
Amiodarone Hcl202$1,973
Diltiazem 24hr Er (Cd)Diltiazem Hcl60$869
SotalolSotalol Hcl24$523
Losartan Potassium56$410
Potassium Chloride20$360
Warfarin Sodium35$358
Metoprolol Tartrate65$221
Pantoprazole Sodium49$207

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$13$143,801136 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 159 clinical cardiac electrophysiology providers in Ohio.

Other clinical cardiac electrophysiology in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →